{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} 314: Polypharmacy: What the Nurse Practitioner Should Know


Audio Session and Presentation Slides from National Conference Nurse Practitioners 2017

This session will assist you in understanding the physiologic changes of aging that impact the pharmacokinetics and pharmacodynamics in older adults and determining the best prescribing strategies to address any adverse impact of polypharmacy on older adults.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Name 5 physiological changes of aging that could impact pharmacokinetics and pharmacodynamics in older adults.
  2. Compare and contrast the Beer's criteria with other criteria sets.
  3. State several adverse effects associated with anticholinergic drugs and list those drugs with the highest anticholinergic activity.
  4. Identify the components of a stepwise approach to prescribing.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. (CE Broker Course #20-621262)

Test Code: ncnpfall2017S314A
Published: October 2017
Expires: 9/6/2019
Sources: National Conference for Nurse Practitioners - Fall 2017
Passing Score: 1/1 (100%)
Authors: Audrey Stevenson PhD, MPH, MSN, FNP-BC, Division Director